FDA links Januvia to pancreatitis - FiercePharma
Links shared publicly online about this topic.
- 1,711total visits
FDA links Januvia to pancreatitis - FiercePharma
View full resource at fiercepharma.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, FDA, Januvia, Merck & Co.
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
Merck Gets FDA Warning Letter on Drug Study - WSJ.com
online.wsj.com — “The FDA said Merck failed to meet a requirement to conduct a safety study in rodents of its blockbuster diabetes drug Januvia.” View full resource at online.wsj.com
Most Recently Shared on February 29, 2012 at 12:46 pm By:
FDA chides Merck to follow up on post-marketing Januvia study. Testing in rodents for pancreatitis risk—WSJ http://t.co/yZgD0xfj $MRK
UPDATE 2-Lilly pancreas drug raises questions-US FDA staff | Reuters
reuters.com — “* FDA staff question efficacy of Lilly's liprotamase * Drug would be first such medicine not made from pigs * Lilly shares slip 0.4 pct in morning trading * U.S. liprotamase sales seen $300 mln in” View full resource at reuters.com
Most Recently Shared on January 10, 2011 at 4:17 pm By:
$LLY seeks US OK for 1st pancreatic drug that's not made from pigs, but #FDA staff question how well it works:http://link.reuters.com/kex55r
No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m
reuters.com — “No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m” View full resource at reuters.com
Most Recently Shared on June 28, 2010 at 10:06 pm By:
No pancreatitis risk seen in Byetta, Januvia drugs http://link.reuters.com/wem64m
NewLink Genetics Receives Special Protocol Assessment Approval From FDA For Pivotal Phase 3 Trial In Pancreatic Cancer
medicalnewstoday.com — “NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 tria” View full resource at medicalnewstoday.com
Most Recently Shared on February 12, 2010 at 3:10 pm By:
NewLink Genetics Receives Special Protocol Assessment Approval From FDA For Pivotal Phase 3 Trial In Pancreatic Cancer http://mnt.to/3xy5
NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer trial
news-medical.net — “NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of” View full resource at news-medical.net
Most Recently Shared on February 12, 2010 at 9:30 am By:
Genetics News: NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer... http://buzzup.com/o1h8
BYETTA RED CODED - TuDiabetes
tudiabetes.com — “KIDNEY FAILURE Health Sciences Institute: Code Red Alert - Why am I getting this? The FDA Really Does Hate Diabetics Killer diabetes drug Byetta has once again been linked to severe organ damage and death... and the FDA has once again made them (can you guess?) change the warning label. Last year, it was increased risk of hemorrhagic pancreatitis (which caused several deaths) that got added to the label. This year, it's kidney problems " including 62 cases of acute kidney failure " which can be ” View full resource at tudiabetes.com
Most Recently Shared on November 6, 2009 at 3:31 am By:
Type 1 diabetes: BYETTA RED CODED: KIDNEY FAILURE Health Sciences Institute: Code Red Alert -.. http://bit.ly/gvY93
BYETTA CAUSING KIDNEY FAILURE - TuDiabetes
tudiabetes.com — “Health Sciences Institute: Code Red Alert - Why am I getting this? The FDA Really Does Hate Diabetics Killer diabetes drug Byetta has once again been linked to severe organ damage and death... and the FDA has once again made them (can you guess?) change the warning label. Last year, it was increased risk of hemorrhagic pancreatitis (which caused several deaths) that got added to the label. This year, it's kidney problems " including 62 cases of acute kidney failure " which can be fatal. What wil” View full resource at tudiabetes.com
Most Recently Shared on November 6, 2009 at 3:17 am By:
TuDiabetes blogs: BYETTA CAUSING KIDNEY FAILURE: Health Sciences Institute: Code Red Alert -.. http://bit.ly/1oakq0
FDA sees pancreatitis link with Merck's Januvia - TuDiabetes
tudiabetes.com — “WASHINGTON, Sept 25 (Reuters) - U.S. health officials said on Friday they suspect Merck & Co Inc's (MRK.N) blockbuster diabetes drug Januvia may be linked to serious cases of inflamed pancreas, but company officials disputed the connection. The Food and Drug Administration said that 88 cases of acute pancreatitis had been reported since the drug's approval in 2006 through February 2009. More details: http://www.reuters.com/article/governmentFilingsNews/idUSN2550919420090925” View full resource at tudiabetes.com
Most Recently Shared on September 30, 2009 at 12:38 am By:
Diabetes news: FDA sees pancreatitis link with Merck's Januvia: WASHINGTON, Sept 25 (Reuters) -.. http://bit.ly/2fGiiO
FDA sees pancreatitis link with Merck's Januvia - TuDiabetes
tudiabetes.com — “WASHINGTON, Sept 25 (Reuters) - U.S. health officials said on Friday they suspect Merck & Co Inc's (MRK.N) blockbuster diabetes drug Januvia may be linked to serious cases of inflamed pancreas, but company officials disputed the connection. The Food and Drug Administration said that 88 cases of acute pancreatitis had been reported since the drug's approval in 2006 through February 2009. More details: http://www.reuters.com/article/governmentFilingsNews/idUSN2550919420090925” View full resource at tudiabetes.com
Most Recently Shared on September 29, 2009 at 7:22 pm By:
FDA sees pancreatitis link with Merck's Januvia http://bit.ly/wkq86 #diabetes
Januvia Linked to Pancreatitis by FDA - Health Blog - WSJ
blogs.wsj.com — “An FDA notice on Merck's Januvia comes just over a year after Byetta was also linked to pancreatitis.” View full resource at blogs.wsj.com
Most Recently Shared on September 28, 2009 at 8:27 pm By:
Diabetes Drug and Pancreatitis: http://bit.ly/3RxqWo #diabetes
Sitagliptin linked to acute pancreatitis, FDA warns
theheart.org — “The FDA is revising prescribing information for sitagliptin and sitagliptin/metformin after cases of acute pancreatitis, some severe, surfaced in postmarketing reports.” View full resource at theheart.org
Most Recently Shared on September 28, 2009 at 5:44 pm By:
heartwire: Sitagliptin linked to acute pancreatitis, FDA warns http://bit.ly/2ZBLGp
If you take Januvia or Janumet check out this link... - TuDiabetes
tudiabetes.com — “If you take Januvia or Janumet check out this link... http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm183764.htm” View full resource at tudiabetes.com
Most Recently Shared on September 28, 2009 at 9:03 am By:
Type 1 diabetes: If you take Januvia or Janumet check out this link...: If you take Januvia o.. http://bit.ly/3pI80t
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 7:03 pm By:
FDA notified healthcare professionals of revisions to include information on reported cases of acute pancreatitis....http://short.to/rthu
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 4:42 am By:
FDA Alert - FDA Revises Januvia/Janumet Prescribing Information to Include Reported Cases of Acute Pancreatitis - http://bit.ly/QlRRO
FDA warns of acute pancreatitis with sitagliptin - MPR
empr.com — “The FDA has notified healthcare professional and patients of revisions to the prescribing information for Merck's Januvia (sitagliptin tablets) and Janumet (sitagliptin/metformin tablets) to include information on reported cases of acute pancreatitis in patients treated with these medications.” View full resource at empr.com
Most Recently Shared on September 25, 2009 at 4:45 pm By:
MPR News: FDA warns of acute pancreatitis with sitagliptin: The FDA has notified healthcare profession.. http://bit.ly/18SK8N
Advertisement

